Driven Brands, North America's largest automotive services company, entered this reporting cycle under unusual circumstances. The company has been working through a financial restatement and delayed regulatory filings, and its November 2 update combined a third-quarter performance snapshot with a revised full-year outlook. For investors, this matters because the announcement clarified both the strength of its core Take 5 franchise and the growing cost of the accounting review. Following a second-quarter report in which EPS missed consensus, the market has been closely watching whether margin pressures and restatement costs would force management to trim its profitability targets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Rather than a full income-statement release, the company provided a third-quarter 2026 performance update alongside its restatement announcement. The highlight was Take 5 Oil Change, which posted 4.9% same-store sales growth and added 27 net new units, extending its streak of same-store sales growth to 25 consecutive quarters.
Management revised its fiscal 2026 outlook downward on profitability. Adjusted EBITDA is now expected to total $410–$430 million, down from the prior range of $430–$460 million, while Adjusted EPS was reduced to $1.10–$1.20 from $1.15–$1.25. Revenue guidance was left unchanged at $1.95–$2.05 billion. The company also trimmed total net unit growth expectations to 80–100 units, citing delays in issuing Franchise Disclosure Documents that have constrained new franchise openings. Restatement-related costs are now projected at a minimum of $50 million for 2026, above the earlier $35–$45 million range, and the company temporarily paused share repurchases until it becomes current on reporting. From what I see, the resilience at Take 5 stands out even as these adjustments weigh on the broader picture.
Investors reacted negatively to the combination of a restatement and a guidance cut. Shares of DRVN traded sharply lower on November 3, falling roughly 10% intraday, as the market weighed Take 5's continued momentum against reduced profitability expectations and rising restatement costs. Sentiment had already been cautious entering the period, given the prior quarter's EPS miss and the company's ongoing filing delays. The downward revision to Adjusted EBITDA and Adjusted EPS, combined with the pause in buybacks, reinforced concerns that the accounting review remains a meaningful overhang on the business.
Looking ahead, investors will watch for the completion of the restatement and the resumption of timely regulatory filings, which management has identified as its top priority. The timing of updated Franchise Disclosure Documents will also be important, since delays have already reduced new-unit openings across the franchise brands.
On the operating side, Take 5 remains the central growth engine, and its 3.5%–4.0% full-year same-store sales target suggests continued momentum despite pressure on lower-income consumers. Margin trends will be another focus, particularly as restatement-related costs are now expected to spill into 2027.
Balance-sheet progress also bears watching. The company has emphasized deleveraging toward its 3.0x net leverage target, and its ability to resume share repurchases once current on filings could influence sentiment. Free cash flow guidance of $125–$145 million was left unchanged, providing a stable anchor amid the restatement. I’m watching this closely as the restatement process unfolds.
In my view, tools like Tickeron’s AI-powered platforms can help cut through the noise when evaluating names facing restatements or guidance shifts. I use the AI Screener to quickly compare DRVN against peers in automotive services based on patterns, fundamentals, and signals, which often surfaces additional context beyond the headline numbers. It has become a regular part of how I screen for comparable opportunities without spending hours on manual reviews.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
DRVN moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend. In 41 of 57 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 72%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on DRVN as a result. In 60 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for DRVN just turned positive on October 08, 2026. Looking at past instances where DRVN's MACD turned positive, the stock continued to rise in 35 of 51 cases over the following month. The odds of a continued upward trend are 69%.
Following a +5.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where DRVN advanced for three days, in 193 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DRVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
DRVN broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DRVN entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. DRVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.518) is normal, around the industry mean (1.415). P/E Ratio (12.720) is within average values for comparable stocks, (11.741). Projected Growth (PEG Ratio) (0.926) is also within normal values, averaging (0.695). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.030) is also within normal values, averaging (0.919).
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DRVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AutomotiveAftermarket